Presidio Partners 2007, L.p. - Net Worth and Insider Trading

Presidio Partners 2007, L.p. Net Worth

The estimated net worth of Presidio Partners 2007, L.p. is at least $2 Million dollars as of 2024-11-13. Presidio Partners 2007, L.p. is the 10% Owner of Neos Therapeutics Inc and owns about 1,599,993 shares of Neos Therapeutics Inc (NEOS) stock worth over $2 Million. Details can be seen in Presidio Partners 2007, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Presidio Partners 2007, L.p. has not made any transactions after 2016-04-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Presidio Partners 2007, L.p.

To

Presidio Partners 2007, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Presidio Partners 2007, L.p. owns 3 companies in total, including VYNE Therapeutics Inc (VYNE) , Neos Therapeutics Inc (NEOS) , and Ardelyx Inc (ARDX) .

Click here to see the complete history of Presidio Partners 2007, L.p.’s form 4 insider trades.

Insider Ownership Summary of Presidio Partners 2007, L.p.

Ticker Comapny Transaction Date Type of Owner
VYNE VYNE Therapeutics Inc 2018-03-02 10 percent owner
NEOS Neos Therapeutics Inc 2016-04-20 10 percent owner
ARDX Ardelyx Inc 2014-06-18 10 percent owner

Presidio Partners 2007, L.p. Latest Holdings Summary

Presidio Partners 2007, L.p. currently owns a total of 1 stock. Presidio Partners 2007, L.p. owns 1,599,993 shares of Neos Therapeutics Inc (NEOS) as of April 20, 2016, with a value of $2 Million.

Latest Holdings of Presidio Partners 2007, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NEOS Neos Therapeutics Inc 2016-04-20 1,599,993 1.15 1,839,992

Holding Weightings of Presidio Partners 2007, L.p.


Presidio Partners 2007, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Presidio Partners 2007, L.p. has made a total of 0 transactions in Neos Therapeutics Inc (NEOS) over the past 5 years. The most-recent trade in Neos Therapeutics Inc is the sale of 20,367 shares on April 20, 2016, which brought Presidio Partners 2007, L.p. around $203,263.

Insider Trading History of Presidio Partners 2007, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Presidio Partners 2007, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Presidio Partners 2007, L.p. Ownership Network

Ownership Network List of Presidio Partners 2007, L.p.

No Data

Ownership Network Relation of Presidio Partners 2007, L.p.

Insider Network Chart

Presidio Partners 2007, L.p. Owned Company Details

What does VYNE Therapeutics Inc do?

Who are the key executives at VYNE Therapeutics Inc?

Presidio Partners 2007, L.p. is the 10 percent owner of VYNE Therapeutics Inc. Other key executives at VYNE Therapeutics Inc include Chief Legal Officer and GC Mutya Harsch , 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Interim CFO Tyler Zeronda .

VYNE Therapeutics Inc (VYNE) Insider Trades Summary

Over the past 18 months, Presidio Partners 2007, L.p. made no insider transaction in VYNE Therapeutics Inc (VYNE). Other recent insider transactions involving VYNE Therapeutics Inc (VYNE) include a net purchase of 13,000 shares made by Patrick G Lepore ,

In summary, during the past 3 months, insiders sold 0 shares of VYNE Therapeutics Inc (VYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VYNE Therapeutics Inc (VYNE) were sold and 13,000 shares were bought by its insiders, resulting in a net purchase of 13,000 shares.

VYNE Therapeutics Inc (VYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

VYNE Therapeutics Inc Insider Transactions

No Available Data

Presidio Partners 2007, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Presidio Partners 2007, L.p.. You might contact Presidio Partners 2007, L.p. via mailing address: 655 Montgomery Street, Suite 6-161, San Francisco Ca 94111.